Puma Biotechnology (NASDAQ:PBYI) Upgraded by StockNews.com to Strong-Buy Rating
Puma Biotechnology (NASDAQ:PBYI – Get Free Report) was upgraded by analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a report released on Sunday. Separately, HC Wainwright reaffirmed a “buy” rating and issued a $7.00 target price on shares of Puma Biotechnology in a research report on Friday, February 28th. Get Our […]
